HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Kemal Sarica Selected Research

Lithotripsy (Extracorporeal Shockwave Lithotripsy)

2/2022Importance of precise imaging for stone identification during shockwave lithotripsy: a critical evaluation of "OptiVision" as a post-processing radiography imaging modality.
12/2021The best treatment approach for lower calyceal stones ≤20 mm in maximal diameter: mini percutaneous nephrolithotripsy, retrograde intrarenal surgery or shock wave lithotripsy. A systematic review and meta-analysis of the literature conducted by the European Section of Uro-Technology and Young Academic Urologists.
8/2021What is the optimal frequency in shock wave lithotripsy for pediatric renal stones? A prospective randomized study.
2/2021Retrograde intrarenal surgery of renal stones: a critical multi-aspect evaluation of the outcomes by the Turkish Academy of Urology Prospective Study Group (ACUP Study).
10/2019Evaluation of the urinary podocalyxin and nephrin excretion levels to determine a safe time interval between two sessions of SWL for renal stones: a non randomized exploratory study.
10/2018Functional and morphological recovery of solitary kidneys after drainage. Double J stent placement vs emergency ureteroscopy: which one is reasonable?
8/2018Procedural sedation and analgesia for pediatric shock wave lithotripsy: a 10 year experience of single institution.
11/2017What are the Benefits and Harms of Ureteroscopy Compared with Shock-wave Lithotripsy in the Treatment of Upper Ureteral Stones? A Systematic Review.
10/2016Retrograde intrarenal surgery (RIRS), regular and small sized percutaneous nephrolithotomy (PCNL) in daily practice: European Association of Urology Section of Urolithiasis (EULIS) Survey.
9/2016The evolution of urolithiasis assessment and management in the new millennium.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Kemal Sarica Research Topics

Disease

22Shock
12/2021 - 01/2003
14Urolithiasis
01/2022 - 02/2007
11Kidney Calculi (Kidney Stone)
09/2022 - 09/2012
7Pain (Aches)
07/2022 - 11/2008
7Urinary Calculi (Urinary Calculus)
01/2022 - 02/2007
6Hydronephrosis
07/2022 - 03/2017
6Urinary Tract Infections (Urinary Tract Infection)
01/2022 - 11/2006
6Ureteral Calculi
08/2021 - 06/2010
6Hyperoxaluria (Oxaluria)
11/2016 - 08/2004
5Renal Colic
10/2016 - 11/2008
5Colic (Abdominal Cramps)
01/2016 - 02/2011
4Calculi (Calculus)
10/2020 - 02/2011
4Ischemia
11/2016 - 08/2003
3Hemorrhage
02/2021 - 03/2010
3Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
03/2010 - 12/2005
2Wounds and Injuries (Trauma)
01/2022 - 03/2008
2Fused Kidney
04/2021 - 09/2018
2Ureteral Obstruction
10/2020 - 02/2011
2Nephrolithiasis
12/2016 - 02/2010
2Hearing Loss (Hearing Impairment)
03/2015 - 07/2014
1Infections
09/2022
1Anuria
07/2022
1Sepsis (Septicemia)
01/2022
1COVID-19
08/2020
1Neurogenic Urinary Bladder (Bladder, Neurogenic)
03/2020
1Postoperative Pain
12/2018
1Solitary Kidney
10/2018
1Prostatic Neoplasms (Prostate Cancer)
12/2017
1Hematuria
08/2017
1Inflammation (Inflammations)
11/2016
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2016
1Renal Tubular Acidosis (Distal Renal Tubular Acidosis)
04/2015
1Hypercalciuria
04/2015
1Cardiovascular Diseases (Cardiovascular Disease)
12/2011
1Edema (Dropsy)
02/2011
1Atherosclerosis
02/2010

Drug/Important Bio-Agent (IBA)

5CalciumIBA
12/2016 - 06/2006
5Verapamil (Calan)FDA LinkGeneric
11/2016 - 08/2004
5Ethylene Glycol (Monoethylene Glycol)IBA
11/2016 - 08/2004
4Analgesics (Analgesic Drugs)IBA
10/2016 - 03/2013
4OxalatesIBA
12/2011 - 08/2004
3AntioxidantsIBA
11/2016 - 03/2008
2Radio-Opaque acrylic resinIBA
02/2022 - 06/2010
2CreatinineIBA
10/2019 - 10/2018
2Calcium OxalateIBA
11/2016 - 12/2011
2TutukonIBA
11/2016 - 08/2015
2Tamsulosin (Flomax)FDA LinkGeneric
08/2015 - 06/2010
2Potassium CitrateFDA LinkGeneric
04/2015 - 08/2004
2AdrenomedullinIBA
10/2003 - 05/2003
1HolmiumIBA
01/2022
1yttrium-aluminum-garnetIBA
01/2022
1Cystine (L-Cystine)IBA
04/2021
1Anti-Bacterial Agents (Antibiotics)IBA
10/2020
1Tazobactam Drug Combination Piperacillin (Zosyn)FDA LinkGeneric
10/2020
1Carbapenems (Carbapenem Antibiotics)IBA
10/2020
1Amikacin (A.M.K)FDA LinkGeneric
10/2020
1Biomarkers (Surrogate Marker)IBA
10/2019
1podocalyxinIBA
10/2019
1nephrinIBA
10/2019
1Anesthetics (Anesthetic Agents)IBA
08/2018
1antineoplaston A10 (A 10)IBA
08/2018
1KetamineFDA LinkGeneric
08/2018
1Midazolam (Versed)FDA LinkGeneric
08/2018
1AndrogensIBA
12/2017
1Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA
08/2017
1Oxidants (Oxidizing Agents)IBA
11/2016
1ZincIBA
11/2016
1mesoglycanIBA
09/2016
1N 30IBA
09/2015
1ThiazidesIBA
04/2015
1calcium phosphateIBA
04/2015
1Ibuprofen (Motrin)FDA LinkGeneric
03/2013
1Doxazosin (Cardura)FDA LinkGeneric
03/2013
1Adrenergic Antagonists (Antiadrenergic Agents)IBA
03/2013
1C-Reactive ProteinIBA
12/2011
1HDL CholesterolIBA
12/2011
1Blood Glucose (Blood Sugar)IBA
12/2011
1CholesterolIBA
12/2011
1Citric Acid (Citrate)FDA LinkGeneric
12/2011
1alpha-1 Adrenergic Receptors (alpha 1 Adrenergic Receptor)IBA
06/2010
1AnticoagulantsIBA
03/2010
1dimethylarginineIBA
02/2010
1Therapeutic UsesIBA
11/2008
1PapaverineIBA
11/2008

Therapy/Procedure

28Lithotripsy (Extracorporeal Shockwave Lithotripsy)
02/2022 - 01/2003
13Percutaneous Nephrolithotomy
01/2022 - 09/2012
7Therapeutics
09/2022 - 03/2010
6Stents
07/2022 - 02/2011
4Anesthesia
01/2022 - 08/2018
2Operative Time
01/2022 - 02/2011
2Length of Stay
02/2021 - 12/2018
2Decompression
10/2018 - 03/2017
2Conservative Treatment
03/2016 - 02/2006
1Minimally Invasive Surgical Procedures
09/2022
1Punctures
01/2022
1Lasers (Laser)
01/2022
1Analgesia
08/2018
1Nephrotomy
03/2017
1Pain Management
03/2016
1Aftercare (After-Treatment)
11/2008